vimarsana.com

Latest Breaking News On - Annika muskantor - Page 1 : vimarsana.com

Net Insight : Interim Report January - March 2024

Net Insight : Invitation to presentation of Net Insight's Interim report January - March 2024 -April 09, 2024 at 05:02 am EDT

Oncopeptides appoints Holger Lembrer as Chief Financial Officer

/PRNewswire/ Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat.

Norway
Iceland
Liechtenstein
Stockholm
Sweden
United-kingdom
Lichtenstein
Monica-shaw
Holger-lembrer
Ernst-young
Rolf-gulliksen
Annika-muskantor

Oncopeptides publishes Q3 report 2022

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat.

Germany
Sweden
Stockholm
United-kingdom
Swedish
Annika-muskantor
Rolf-gulliksen
Jakob-lindberg
Sweden-innovation-agency
Oncologic-drugs-advisory-committee
European-union
European-commission

Oncopeptides AB: Oncopeptides publishes Q3 report 2022

STOCKHOLM, Nov. 9, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological

Germany
Sweden
Stockholm
United-kingdom
Swedish
Annika-muskantor
Rolf-gulliksen
Jakob-lindberg
Sweden-innovation-agency
Oncologic-drugs-advisory-committee
European-union
European-commission

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.